Related articles
The investment companies set to benefit after rates peak
Related Industry News
Witan puts its £1.6bn global mandate in play as Bell plans to retire
Update: Global multi-manager trust invites fund managers to bid for its mandate as it reviews its self-managed status after chief executive Andrew Bell announces his wish to retire.
David Stevenson: Biotech has turned from the bear
After a tough few years, increased fundraising suggests sentiment has improved and the current rally in biotech and life sciences could persist.
On a 37% discount, Syncona sees first shoots of recovery from the biotech bear market
The listed life sciences fund posts a 5.4% gain for the last quarter, raising hopes of a turnaround after a tough six years.
Distressed Syncona sees first shoots of recovery from biotech bear market
The listed life sciences fund posts a 5.4% gain for the last quarter, raising hopes of a turnaround after a tough six years.
Investment company news brought to you by Citywire Financial Publishers Limited
and QuotedData by Marten & Co.
Data provided by Morningstar.
Company documents provided by FE fundinfo.